ScreenerHero

TLRY Tilray Brands, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · tilray.com
3.715USD-1.72%Mkt Cap: 549.01M $P/E: —

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, a…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap549.01M USD
Enterprise Value660.29M USD
Revenue (TTM)915.45M USD
Gross Profit260.44M USD
Net Income (TTM)-121.40M USD
Revenue/Share8.19 USD
Last Price3.715 USD
Fiscal Year EndMay 2026
MR QuarterMay 2026
Employees3.6K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)21.29
PEG—
EV/EBITDA44.02
EV/Revenue0.72
P/S0.61
P/B0.31
EPS (TTM)-1.09
EPS (Forward)0.18
52W Range
3.5401% of range23.20
52W High23.20 USD
52W Low3.540 USD
Profitability
Gross Margin28.45%
Oper. Margin-0.83%
EBITDA Margin1.64%
Profit Margin-13.26%
ROE-7.52%
ROA-5.21%
Growth
Revenue Growth25.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-69.14M USD
CapEx (TTM)32.99M USD
FCF Margin-2.73%
FCF Yield-4.56%
Net Debt167.13M USD
Net Debt/EBITDA11.14
Balance Sheet
Debt/Equity0.25
Current Ratio2.21
Quick Ratio1.17
Book Value/Sh12.31 USD
Cash/Share1.71 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateDec 2, 2025
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.156 USD
Upside (mean)+92.6%
Target Range4.000 USD – 17.00 USD
4.000+92.6% to mean17.00
# Analysts8
Ownership
Shares Out.147.78M
Float133.34M
Insiders1.59%
Institutions10.08%
Short Interest
Short Ratio5.3d
Short % Float13.92%
Short % Out.13.83%
Shares Short19.42M
Short (prev mo.)18.43M
Technical
SMA 504.319 (-14.0%)
SMA 2006.121 (-39.3%)
Beta1.92
S&P 52W Chg15.78%
Avg Vol (30d)3.86M
Avg Vol (10d)4.20M
Technical Indicators
RSI (14)37.0
MACD-0.1935
MACD Signal-0.1690
MACD Hist.-0.0245
BB Upper4.483 USD
BB Middle3.997 USD
BB Lower3.511 USD
BB Width24.31%
ATR (14)0.1811 USD
Vol Ratio (20d)0.83x